PGT-A: principles and limits
On this page you will learn
- What aneuploidy is and why it matters for embryos
- How PGT-A reads chromosome copy number from a biopsy
- What mosaic results mean and why they are difficult
- The scientific and ethical limits of PGT-A
Aneuploidy
An embryo with the wrong number of chromosomes is aneuploid. Most aneuploidy in human embryos comes from errors during female meiosis (page 21), and the chance of those errors rises as the woman gets older. Some errors also arise after fertilisation, during the early cell divisions. Many aneuploid embryos stop developing, fail to implant or end in miscarriage. Pre-implantation genetic testing for aneuploidy (PGT-A) aims to identify them before transfer.
How the test works
The trophectoderm biopsy (page 57) is sent to a genetics laboratory. The DNA from the few cells is amplified, then sequenced, most often by next-generation sequencing. The laboratory counts how much DNA comes from each chromosome and compares it with a reference. A chromosome that appears in three copies, or in one, shows as a gain or a loss. The report classifies the embryo, typically as euploid (normal number), aneuploid, mosaic or no result.
The test measures copy number. It does not test for every genetic condition, it does not detect all structural changes, and it does not say whether an embryo will implant.
Mosaicism
Some embryos contain a mixture of cells with different chromosome numbers. This is mosaicism. A biopsy of a few cells may show an intermediate result, between normal and abnormal. The difficulty is that the biopsy is a tiny sample of the trophectoderm, which may not reflect the inner cell mass. Some embryos reported as mosaic have led to healthy births, and international professional bodies have published guidance on how to counsel couples and rank mosaic embryos. A mosaic result is therefore not a simple yes or no; it is a discussion between the clinician, a genetic counsellor and the couple.
Limits you must be able to explain
- False results: amplification problems, technical noise and mosaicism can cause an embryo to be wrongly labelled normal or abnormal. A normal embryo may be discarded.
- No result: a few biopsies give no usable DNA. The embryo may need a second biopsy and second vitrification, or be transferred without a result after discussion.
- Benefit is not universal: PGT-A does not create healthy embryos; it can only help to choose among those already there. Trials have not shown that it increases the overall chance of a baby from a treatment cycle for all couples, and its use remains debated.
- Harms: biopsy and an extra vitrification add handling; cost is significant; some couples end with no embryo to transfer.
Honest teaching of PGT-A says what it can and cannot do. You will meet couples, and colleagues, who believe it promises a healthy pregnancy. Correct that belief politely and leave counselling to the clinician and the genetic counsellor.
Law in India
The ART (Regulation) Act 2021 permits pre-implantation genetic testing of embryos to screen for known, pre-existing, heritable or genetic diseases, under the conditions it sets, with consent. How these conditions apply to PGT-A is a matter for the current Rules and your clinic's legal advice, not for the laboratory to decide. The PCPNDT Act prohibits using any test to identify or reveal the sex of an embryo or fetus for that purpose, and prohibits choosing embryos by sex. Sex chromosome copy number may appear in the raw data because the method reads all chromosomes; such information is never disclosed and never used to choose embryos. The ICMR national ART guidelines also apply. Read the current text of each before you work in a programme that offers PGT.
At the bench: your part in PGT-A
The embryologist's part of PGT-A is the biopsy, tubing, labelling, vitrification and shipping (page 57), and later warming the chosen embryo (page 52). On Day 12 you complete a paper exercise: match a sample PGT-A report to a practice storage map, identify which devices the clinician has chosen, and flag any mismatch. It is the same traceability skill as page 55.
Common errors
- Describing PGT-A as a test for "all genetic diseases".
- Treating a mosaic result as simply abnormal or simply normal.
- Mismatching a report line to the wrong storage device.
- Passing on any information about embryo sex.
Check yourself
- Where does most embryo aneuploidy come from?
- What does next-generation sequencing measure in a PGT-A test?
- Explain why a mosaic result is hard to interpret.
- Give two limits of PGT-A that you would explain to a colleague.
Questions on this page
Does a euploid result mean the pregnancy will succeed?
No. A euploid embryo can still fail to implant or miscarry, because implantation depends on many other factors.
Should every IVF cycle include PGT-A?
Current evidence does not support routine use for everyone. Whether it is offered is a clinical decision made with the couple.
What happens if the test gives no result?
The clinician discusses the options with the couple, which may include re-biopsy or transfer without a result.
The Genesis ART Textbook is teaching text for trainees and doctors of the Genesis ART Academy. It is not treatment advice and not a laboratory standard operating procedure; every technique is learned under supervision. Page numbers never change.
